Regeneron Announces Upcoming 2013 Investor Conference Presentations

     Regeneron Announces Upcoming 2013 Investor Conference Presentations

PR Newswire

TARRYTOWN, N.Y., Feb. 19, 2013

TARRYTOWN,N.Y., Feb. 19, 2013 /PRNewswire/ --Regeneron Pharmaceuticals, Inc.
(NASDAQ: REGN) will webcast management presentations at the following investor
conferences:

  oCiti 2013 Global Healthcare Conference; Dyslipidemia Panel on Tuesday,
    February 26, 2013. The session is scheduled for 1:30 p.m. Eastern Time.
  oRBC Capital Markets' 2013 Global Healthcare Conference on Wednesday,
    February 27, 2013. The presentation is scheduled for 9:30 a.m. Eastern
    Time.
  oBarclays Global Healthcare Conference on Tuesday, March 12, 2013. The
    presentation is scheduled for 2:30 p.m. Eastern Time.

The sessions may be accessed through the Company's web site,
www.regeneron.com, on the 'Events and Presentations' page. An archived
version of the presentations will be available for 30 days.

About Regeneron Pharmaceuticals, Inc.
Regeneron is a leading science-based biopharmaceutical company based in
Tarrytown, New York that discovers, invents, develops, manufactures, and
commercializes medicines for the treatment of serious medical conditions.
Regeneron markets medicines for eye diseases, colorectal cancer, and a rare
inflammatory condition and has product candidates in development in other
areas of high unmet medical need, including hypercholesterolemia, rheumatoid
arthritis, and asthma. For additional information about the company, please
visit www.regeneron.com.

Contact Information:
Michael Aberman, M.D.         Peter Dworkin
Investor Relations            Corporate
                              Communications
914.847.7799                  914.847.7640 
michael.aberman@regeneron.com peter.dworkin@regeneron.com

SOURCE Regeneron Pharmaceuticals, Inc.

Website: http://www.regeneron.com
 
Press spacebar to pause and continue. Press esc to stop.